The history, advantages and limitations of point-of-care testing for blood glucose
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378926179 | ||
| 003 | CHVBK | ||
| 005 | 20180305123618.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20040617xx s 000 0 mul | ||
| 024 | 7 | 0 | |a 10.1515/LabMed.2004.036 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/LabMed.2004.036 | ||
| 100 | 1 | |a Nichols |D J.H. | |
| 245 | 1 | 4 | |a The history, advantages and limitations of point-of-care testing for blood glucose |h [Elektronische Daten] |c Geschichte, Vorteile und Grenzen des Point-of-Care-Testing im Bereich der Blutzuckerkontrolle / [J.H. Nichols] |
| 520 | 3 | |a Glucose testing has evolved from primitive urine tasting and chemical tests to sophisticated enzymatic and biosensor technologies with computerized data recording capabilities. Glucose monitoring will become more important in the future, as the incidence of diabetes increases. Current meters allow for the rapid analysis of small amounts of blood in a variety of healthcare settings, but suffer from the instability and common interferences of their enzyme-based technologies. Although the performance of glucose meters is not yet as accurate as laboratory methods, glucose meters provide a reasonable estimate to base insulin management and trend glucose control. Glucose self-management delays the onset of diabetic complications and intensive monitoring of surgical inpatients improves patient outcome. Future research promises to develop less invasive and more continuous monitoring methods. While there is currently no cure for diabetes, the advent of glucose meters and monitoring technologies has provided new insights into the nature of the disease and made diabetes a more manageable disorder. | |
| 540 | |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Medical equipment & techniques |2 nationallicence | |
| 690 | 7 | |a Medical diagnosis |2 nationallicence | |
| 690 | 7 | |a Diseases & disorders |2 nationallicence | |
| 773 | 0 | |t LaboratoriumsMedizin |d Walter de Gruyter |g 28/3(2004-06-17), 245-250 |x 0342-3026 |q 28:3<245 |1 2004 |2 28 |o labm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/LabMed.2004.036 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/LabMed.2004.036 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 100 |E 1- |a Nichols |D J.H. | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t LaboratoriumsMedizin |d Walter de Gruyter |g 28/3(2004-06-17), 245-250 |x 0342-3026 |q 28:3<245 |1 2004 |2 28 |o labm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||